Value of Laboratory Indicators in Predicting Pneumonia in Symptomatic COVID-19 Patients Infected with the SARS-CoV-2 Omicron Variant

References

• Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected Pneumonia. N Engl J Med. 2020;382(13):1199–1207. doi:10.1056/NEJMoa2001316
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Viana R, Moyo S, Amoako DG, et al. Rapid epidemic expansion of the SARS-CoV-2 omicron variant in Southern Africa. Nature. 2022;603(7902):679–686. doi:10.1038/s41586-022-04411-y
   PubMed Web of Science ®Google Scholar
• Balint G, Voros-Horvath B, Szechenyi A. Omicron: increased transmissibility and decreased pathogenicity. Signal Transduct Target Ther. 2022;7(1):151. doi:10.1038/s41392-022-01009-8
   PubMed Web of Science ®Google Scholar
• Harrigan SP, Wilton J, Chong M, et al. Clinical severity of omicron SARS-CoV-2 variant relative to delta in British Columbia, Canada: a retrospective analysis of whole genome sequenced cases. Clin Infect Dis. 2022. doi:10.1093/cid/ciac705
   PubMed Web of Science ®Google Scholar
• Ito N, Kitahara Y, Miwata K, Okimoto M, Takafuta T. Comparison of COVID-19 pneumonia during the SARS-CoV-2 omicron wave and the previous non-omicron wave in a single facility. Respir Investig. 2022;60(6):772–778. doi:10.1016/j.resinv.2022.08.001
   PubMed Web of Science ®Google Scholar
• Jassat W, Abdool KS, Mudara C, et al. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study. Lancet Glob Health. 2022;10(7):e961–e969. doi:10.1016/S2214-109X(22)00114-0
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhan C, Chen C, Ai T, Xia L, Adrish M. Chest CT findings related to mortality of patients with COVID-19: a retrospective case-series study. PLoS One. 2020;15(8):e0237302. doi:10.1371/journal.pone.0237302
   PubMed Web of Science ®Google Scholar
• Li K, Wu J, Wu F, et al. The clinical and chest CT features associated with severe and critical COVID-19 Pneumonia. Invest Radiol. 2020;55(6):327–331. doi:10.1097/RLI.0000000000000672
   PubMed Web of Science ®Google Scholar
• Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between chest CT findings and clinical conditions of Coronavirus Disease (COVID-19) Pneumonia: a multicenter study. AJR Am J Roentgenol. 2020;214(5):1072–1077. doi:10.2214/AJR.20.22976
   PubMed Web of Science ®Google Scholar
• Leonard-Lorant I, Severac F, Bilbault P, et al. Normal chest CT in 1091 symptomatic patients with confirmed Covid-19: frequency, characteristics and outcome. Eur Radiol. 2021;31(7):5172–5177. doi:10.1007/s00330-020-07593-z
   PubMed Web of Science ®Google Scholar
• Komurcuoglu B, Susam S, Batum O, et al. Correlation between chest CT severity scores and clinical and biochemical parameters of COVID-19 pneumonia. Clin Respir J. 2022;16(7):497–503. doi:10.1111/crj.13515
   PubMed Web of Science ®Google Scholar
• Nakajima K, Kato H, Yamashiro T, et al. COVID-19 pneumonia: infection control protocol inside computed tomography suites. Jpn J Radiol. 2020;38(5):391–393. doi:10.1007/s11604-020-00948-y
   PubMed Web of Science ®Google Scholar
• Kinikar AA, Vartak S, Dawre R, et al. Clinical profile and outcome of hospitalized confirmed cases of omicron variant of SARS-CoV-2 among children in Pune, India. Cureus. 2022;14(4):e24629. doi:10.7759/cureus.24629
   PubMed Web of Science ®Google Scholar
• Tong X, Huang Z, Zhang X, et al. Old age is an independent risk factor for Pneumonia development in patients with SARS-CoV-2 omicron variant infection and a history of inactivated vaccine injection. Infect Drug Resist. 2022;15:5567–5573. doi:10.2147/IDR.S380005
   PubMed Web of Science ®Google Scholar
• Murillo-Zamora E, Trujillo X, Huerta M, et al. First-generation BNT162b2 and AZD1222 vaccines protect from COVID-19 pneumonia during the omicron variant emergence. Public Health. 2022;207:105–107. doi:10.1016/j.puhe.2022.04.001
   PubMed Web of Science ®Google Scholar
• Agrawal U, Bedston S, Mccowan C, et al. Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales. Lancet. 2022;400(10360):1305–1320. doi:10.1016/S0140-6736(22)01656-7
   PubMed Web of Science ®Google Scholar
• Suzuki K, Ichikawa T, Suzuki S, Tanino Y, Kakinoki Y. Clinical characteristics of the severe acute respiratory syndrome coronavirus 2 omicron variant compared with the delta variant: a retrospective case-control study of 318 outpatients from a single sight institute in Japan. Peerj. 2022;10:e13762. doi:10.7717/peerj.13762
   PubMed Web of Science ®Google Scholar
• Abu-Raddad LJ, Chemaitelly H, Ayoub HH, et al. Effect of mRNA vaccine boosters against SARS-CoV-2 omicron infection in Qatar. N Engl J Med. 2022;386(19):1804–1816. doi:10.1056/NEJMoa2200797
   PubMed Web of Science ®Google Scholar
• Accorsi EK, Britton A, Fleming-Dutra KE, et al. Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 omicron and delta variants. JAMA. 2022;327(7):639–651. doi:10.1001/jama.2022.0470
   PubMed Web of Science ®Google Scholar
• Bjork J, Bonander C, Moghaddassi M, et al. COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 omicron BA.1 and BA.2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022. Euro Surveill. 2022;27(18):2200322. doi:10.2807/1560-7917.ES.2022.27.18.2200322
   PubMedGoogle Scholar
• Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768. doi:10.1093/cid/ciaa248
   PubMed Web of Science ®Google Scholar
• Abrishami A, Eslami V, Arab-Ahmadi M, Alahyari S, Azhideh A, Sanei-Taheri M. Prognostic value of inflammatory biomarkers for predicting the extent of lung involvement and final clinical outcome in patients with COVID-19. J Res Med Sci. 2021;26:115. doi:10.4103/jrms.JRMS_1160_20
   PubMedGoogle Scholar
• Boncuoglu E, Coskun M, Kiymet E, et al. Can laboratory findings predict pulmonary involvement in children with COVID-19 infection? Pediatr Pulmonol. 2021;56(8):2489–2494. doi:10.1002/ppul.25452
   PubMed Web of Science ®Google Scholar
• Wang Q, Cheng J, Shang J, et al. Clinical value of laboratory indicators for predicting disease progression and death in patients with COVID-19: a retrospective cohort study. BMJ Open. 2021;11(10):e043790. doi:10.1136/bmjopen-2020-043790
   PubMed Web of Science ®Google Scholar
• Seyit M, Avci E, Nar R, et al. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med. 2021;45:569. doi:10.1016/j.ajem.2020.12.069
   PubMed Web of Science ®Google Scholar
• Yu GQ, Zhang Q, Wang RC, Jiang SQ. Predictive value of neutrophil-to-lymphocyte ratio and other inflammatory indicators in estimating clinical severity of coronavirus disease. World J Emerg Med. 2021;12(1):79–80. doi:10.5847/wjem.j.1920-8642.2021.01.014
   PubMed Web of Science ®Google Scholar
• Ye W, Chen G, Li X, et al. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19. Respir Res. 2020;21(1):169. doi:10.1186/s12931-020-01428-7
   PubMed Web of Science ®Google Scholar
• Wang L, Yang L, Bai L, Huang Z, Peng Y. Association between D-dimer level and chest CT severity score in patients with SARS-COV-2 pneumonia. Sci Rep. 2021;11(1):11636. doi:10.1038/s41598-021-91150-1
   PubMedGoogle Scholar
• Yao Y, Cao J, Wang Q, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care. 2020;8:49. doi:10.1186/s40560-020-00466-z
   PubMed Web of Science ®Google Scholar
• Ozen M, Yilmaz A, Cakmak V, et al. D-dimer as a potential biomarker for disease severity in COVID-19. Am J Emerg Med. 2021;40:55–59. doi:10.1016/j.ajem.2020.12.023
   PubMed Web of Science ®Google Scholar
• Hu X, Xing Y, Jia J, et al. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19. Sci Total Environ. 2020;728:138812. doi:10.1016/j.scitotenv.2020.138812
   PubMed Web of Science ®Google Scholar
• Benoni R, Campagna I, Panunzi S, et al. Estimating COVID-19 recovery time in a cohort of Italian healthcare workers who underwent surveillance swab testing. Public Health. 2021;196:52–58. doi:10.1016/j.puhe.2021.05.014
   PubMed Web of Science ®Google Scholar
• Sun J, Zheng Q, Madhira V, et al. Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US. JAMA Intern Med. 2022;182(2):153–162. doi:10.1001/jamainternmed.2021.7024
   PubMed Web of Science ®Google Scholar
• Zhang X, Wu S, Wu B, et al. SARS-CoV-2 omicron strain exhibits potent capabilities for immune evasion and viral entrance. Signal Transduct Target Ther. 2021;6(1):430. doi:10.1038/s41392-021-00852-5
   PubMed Web of Science ®Google Scholar
• Andrews N, Stowe J, Kirsebom F, et al. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant. N Engl J Med. 2022;386(16):1532–1546. doi:10.1056/NEJMoa2119451
   PubMed Web of Science ®Google Scholar
• Altarawneh HN, Chemaitelly H, Ayoub HH, et al. Effects of previous infection and vaccination on symptomatic omicron infections. N Engl J Med. 2022;387(1):21–34. doi:10.1056/NEJMoa2203965
   PubMed Web of Science ®Google Scholar
• Fors M, Ballaz S, Ramirez H, et al. Sex-dependent performance of the neutrophil-to-lymphocyte, monocyte-to-lymphocyte, platelet-to-lymphocyte and mean platelet volume-to-platelet ratios in discriminating COVID-19 severity. Front Cardiovasc Med. 2022;9:822556. doi:10.3389/fcvm.2022.822556
   PubMed Web of Science ®Google Scholar
• Vafadar ME, Teimouri A, Rezaee R, et al. Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality. Am J Emerg Med. 2021;40:11–14. doi:10.1016/j.ajem.2020.12.003
   PubMed Web of Science ®Google Scholar
• Damar CT, Torun A, Cakirca G, Portakal RD. Role of NLR, PLR, ELR and CLR in differentiating COVID-19 patients with and without pneumonia. Int J Clin Pract. 2021;75(11):e14781. doi:10.1111/ijcp.14781
   PubMed Web of Science ®Google Scholar
• Shorr AF, Thomas SJ, Alkins SA, Fitzpatrick TM, Ling GS. D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest. 2002;121(4):1262–1268. doi:10.1378/chest.121.4.1262
   PubMed Web of Science ®Google Scholar
• Borowiec A, Dabrowski R, Kowalik I, et al. Elevated levels of d-dimer are associated with inflammation and disease activity rather than risk of venous thromboembolism in patients with granulomatosis with polyangiitis in long term observation. Adv Med Sci. 2020;65(1):97–101. doi:10.1016/j.advms.2019.12.007
   PubMed Web of Science ®Google Scholar
• Hayiroglu MI, Cinar T, Tekkesin AI. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review. Rev Assoc Med Bras. 2020;66(6):842–848. doi:10.1590/1806-9282.66.6.842
   PubMed Web of Science ®Google Scholar
• Murat S, Murat B, Dural M, Mert GO, Cavusoglu Y. Prognostic value of D-dimer/fibrinogen ratio on in-hospital outcomes of patients with heart failure and COVID-19. Biomark Med. 2021;15(16):1519–1528. doi:10.2217/bmm-2021-0341
   PubMed Web of Science ®Google Scholar